These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11093813)

  • 1. Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer.
    Maacke H; Opitz S; Jost K; Hamdorf W; Henning W; Krüger S; Feller AC; Lopens A; Diedrich K; Schwinger E; Stürzbecher HW
    Int J Cancer; 2000 Dec; 88(6):907-13. PubMed ID: 11093813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.
    Hallajian Z; Mahjoubi F; Nafissi N
    Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
    Butcher DT; Rodenhiser DI
    Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible function found for breast cancer genes.
    Marx G
    Science; 1997 Apr; 276(5312):531-2. PubMed ID: 9148411
    [No Abstract]   [Full Text] [Related]  

  • 5. PML protein expression in hereditary and sporadic breast cancer.
    Plevová P; Bouchal J; Fiurásková M; Foretová L; Navrátilová M; Zapletalová J; Curík R; Kubala O; Prokop J; Kolár Z
    Neoplasma; 2007; 54(4):263-8. PubMed ID: 17822314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [BRCA1 selectively regulates the expression of progesterone receptor A in sporadic invasive ductal breast carcinoma].
    Wang X; Zhao T; Zhao JJ; Xiong JB
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1399-402. PubMed ID: 20646629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
    Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation in the 5' untranslated region of the BRCA1 gene in sporadic breast cancer causes downregulation of translation efficiency.
    Wang J; Lu C; Min D; Wang Z; Ma X
    J Int Med Res; 2007; 35(4):564-73. PubMed ID: 17697535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.
    Martin RW; Orelli BJ; Yamazoe M; Minn AJ; Takeda S; Bishop DK
    Cancer Res; 2007 Oct; 67(20):9658-65. PubMed ID: 17942895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of BRCA1 and WWOX and their clinicopathologic implication in breast carcinomas occurring in young women].
    Zhang QL; Zhang QH; Cong H; Zhang XL
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):90-4. PubMed ID: 23710914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA-associated breast cancer: absence of a characteristic immunophenotype.
    Robson M; Rajan P; Rosen PP; Gilewski T; Hirschaut Y; Pressman P; Haas B; Norton L; Offit K
    Cancer Res; 1998 May; 58(9):1839-42. PubMed ID: 9581822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
    Yoshikawa K; Ogawa T; Baer R; Hemmi H; Honda K; Yamauchi A; Inamoto T; Ko K; Yazumi S; Motoda H; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
    Int J Cancer; 2000 Oct; 88(1):28-36. PubMed ID: 10962436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
    Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
    Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of BRCA1 with Rad51 in mitotic and meiotic cells.
    Scully R; Chen J; Plug A; Xiao Y; Weaver D; Feunteun J; Ashley T; Livingston DM
    Cell; 1997 Jan; 88(2):265-75. PubMed ID: 9008167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
    Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
    Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
    Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
    Yuan SS; Lee SY; Chen G; Song M; Tomlinson GE; Lee EY
    Cancer Res; 1999 Aug; 59(15):3547-51. PubMed ID: 10446958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
    Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
    Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ
    Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.
    King TA; Gemignani ML; Li W; Giri DD; Panageas KS; Bogomolniy F; Arroyo C; Olvera N; Robson ME; Offit K; Borgen PI; Boyd J
    Cancer Res; 2004 Aug; 64(15):5051-3. PubMed ID: 15289302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.